Steven Chan

Steven Chan is an accomplished finance executive with extensive experience in the biotechnology and technology sectors. Currently serving as Chief Financial Officer at Attovia Therapeutics since October 2024, Steven previously held the CFO position at Connect Biopharma, overseeing financial strategy for a clinical-stage biopharmaceutical company focused on chronic inflammatory diseases. Additional roles include CFO at Delphon, Vice President of Finance & Corporate Controller at Arcus Biosciences, where Steven played a key role in a $120M IPO, and similar positions at MyoKardia and Solta Medical, contributing to significant public transitions. Steven's career also encompasses leadership roles at Moody's Analytics, Polycom, Logitech, and Sun Microsystems. Educational qualifications include an Executive CFO degree from Columbia Business School and a Bachelor of Science in Business Administration from the University of California, Berkeley.